*This blog was written by Digamma Consulting and provided to Sapphire Risk Advisory Group to publish on their behalf. As the cannabis industry evolves, so does the regulatory landscape governing its operations. With the potential reclassification of cannabis to Schedule III under the Controlled Substances Act , cannabis testing labs and product manufacturers must brace for significant changes. At Digamma …